Frazier Life Sciences Management’s Epizyme, Inc EPZM Stock Holding History

Frazier Life Sciences Management’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-739,369	Closed	-$1.09M	–	46
2022 Q2	$1.09M	Hold	739,369	–	–	0.1%	39
2022 Q1	$850K	Buy	+739,369	New	+$1.21M	0.07%	41

Other funds holding EPZM

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Frazier Life Sciences Management's EPZM Position: Q3 2022 in Review

Frazier Life Sciences Management sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 739,369 shares — an estimated $1.09M sold.

Frazier Life Sciences Management first reported a position in EPZM in Q1 2022 and held it in 2 quarters. The position peaked at $1.09M in Q2 2022. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.

Frazier Life Sciences Management reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
Frazier Life Sciences Management sold 739,369 Epizyme, Inc shares in Q3 2022, an estimated $1.09M.
Frazier Life Sciences Management first reported a position in Epizyme, Inc in Q1 2022 and held it in 2 quarters.
Frazier Life Sciences Management's Epizyme, Inc position peaked at $1.09M in Q2 2022.
0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.

Based on Frazier Life Sciences Management's 13F filing for Q3 2022, filed 14 Nov 2022.